The present invention provides nucleic acid sequences coding for the Cryptomeria japonica major pollen allergen Cry j I, Cry j II, Jun s I and Jun v I and fragments or peptides thereof. The present invention also provides purified Cry j I, Cry j II, Jun s I and Jun v I and at least one fragment thereof produced in a host cell transformed with a nucleic acid sequence coding for Cry j I, Cry j II, Jun s I and Jun v I or at least one fragment thereof, and fragments of Cry j I, Cry j II, Jun s I or Jun v I or at least one fragment thereof, and fragments of Cry j I, Cry j II, Jun s I or Jun v I prepared synthetically. Cry j I, Cry j II, Jun s I and Jun v I and fragments thereof are useful for diagnosing, treating, and preventing Japanese cedar pollinosis. The present invention also provides isolated peptides of Cry j I and Cry j II. Peptides within the scope of the invention comprise at least one T cell epitope, or preferably at least two T cell epitopes of Cry j I or Cry j II. The invention also pertains to modified peptides having similar or enhanced therapeutic properties as the corresponding naturally-occurring allergen or portion thereof but having reduced side effects. Methods of treatment or of diagnosis of sensitivity to Japanese cedar pollens in an individual and therapeutic compositions, and multipeptide formulations comprising one or more peptides of the invention are also provided.

Griffith; Irwin J.

Pollock; Joanne

Bond; Julian F.

Garman; Richard D.

Kuo; Mei-Chang

Powers; Stephen P.

Exley; Mark A.

Chen; Xian

Shaked; Ze'ev

Merck Patent GmbH

Allergenic proteins and peptides from Japanese cedar pollen

ImmuLogic Pharmaceutical Corporation

T cell peptides of the CRX JII allergen

cryptomeria

antimykotikum

antifungal

cryptomeria/antimykotikum

Allergenic proteins and peptides from Japanese cedar pollen

Allergenic proteins and peptides from Japanese cedar pollen

T cell peptides of the CRX JII allergen

Die vollständigste Datenbank für Heilkräuter, die von der Wissenschaft unterstützt wird